Financials ASCENT INDUSTRIES CORP Canadian Securities Exchange

Equities

HERB

CA42704B1067

Pharmaceuticals

Market Closed - Canadian Securities Exchange 03:27:35 2024-04-26 pm EDT 5-day change 1st Jan Change
0.05 CAD +11.11% Intraday chart for ASCENT INDUSTRIES CORP 0.00% 0.00%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 60.82 32.02 5.851 6.473 3.668
Enterprise Value (EV) 1 64.74 27.7 6.154 2.376 3.396
P/E ratio -2.03 x -1.43 x -0.84 x -2.53 x -0.54 x
Yield - - - - -
Capitalization / Revenue 22.6 x 43 x 291 x 9.46 x 11.5 x
EV / Revenue 24.1 x 37.2 x 306 x 3.47 x 10.7 x
EV / EBITDA -3.16 x -2.72 x -1.87 x -0.76 x -1.27 x
EV / FCF -5.08 x -11.4 x -2.51 x -1.59 x -5.28 x
FCF Yield -19.7% -8.8% -39.9% -63% -18.9%
Price to Book 1.7 x 2.43 x 0.69 x 1 x 0.58 x
Nbr of stocks (in thousands) 32,009 32,015 39,008 43,154 73,355
Reference price 2 1.900 1.000 0.1500 0.1500 0.0500
Announcement Date 5/11/20 5/11/20 4/21/21 4/12/22 4/28/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 4.88 2.688 0.744 0.0201 0.6842 0.3188
EBITDA 1 -2.316 -20.46 -10.18 -3.284 -3.118 -2.673
EBIT 1 -2.746 -23.36 -10.97 -4.098 -3.682 -2.9
Operating Margin -56.27% -868.9% -1,475.03% -20,406.36% -538.14% -909.79%
Earnings before Tax (EBT) 1 -2.942 -30.49 -22.39 -6.435 -2.381 -4.578
Net income 1 -2.942 -29.77 -22.4 -6.438 -2.396 -4.615
Net margin -60.29% -1,107.63% -3,010.1% -32,061.99% -350.13% -1,447.78%
EPS 2 -0.2083 -0.9368 -0.6996 -0.1780 -0.0593 -0.0923
Free Cash Flow 1 -15.79 -12.75 -2.438 -2.454 -1.498 -0.6429
FCF margin -323.46% -474.47% -327.73% -12,219.52% -218.98% -201.7%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 7/4/18 5/11/20 5/11/20 4/21/21 4/12/22 4/28/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 4.96 3.93 - 0.3 - -
Net Cash position 1 - - 4.32 - 4.1 0.27
Leverage (Debt/EBITDA) -2.144 x -0.1919 x - -0.0922 x - -
Free Cash Flow 1 -15.8 -12.8 -2.44 -2.45 -1.5 -0.64
ROE (net income / shareholders' equity) -38.2% -83.8% -91.6% -59.5% -32.1% -72.3%
ROA (Net income/ Total Assets) -14% -29.7% -22.5% -20.3% -24.5% -23.9%
Assets 1 21.01 100.2 99.44 31.69 9.786 19.34
Book Value Per Share 2 0.0600 1.120 0.4100 0.2200 0.1500 0.0900
Cash Flow per Share 2 0.0100 0.0400 0.1200 0.0500 0.0900 0.0200
Capex 1 7.92 21.6 - 0.09 0.08 0.03
Capex / Sales 162.31% 802.08% - 430.8% 12.07% 10.42%
Announcement Date 7/4/18 5/11/20 5/11/20 4/21/21 4/12/22 4/28/23
1CAD in Million2CAD
Estimates
  1. Stock Market
  2. Equities
  3. HERB Stock
  4. HERB Stock
  5. Financials ASCENT INDUSTRIES CORP